BALFX | MTRIX | BALFX / MTRIX | |
Total Expense Ratio | 0.61 | 0.47 | 130% |
Annual Report Gross Expense Ratio | 0.61 | 0.47 | 130% |
Fund Existence | 24 years | 28 years | - |
Gain YTD | 4.526 | 2.944 | 154% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 245B | 7.55B | 3,246% |
Annual Yield % from dividends | 1.88 | 2.59 | 73% |
Returns for 1 year | 4.44 | 0.66 | 670% |
Returns for 3 years | 34.20 | 14.09 | 243% |
Returns for 5 years | 37.48 | 12.73 | 294% |
Returns for 10 years | 57.42 | 31.28 | 184% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETNHX | 32.76 | 0.27 | +0.83% |
Eventide Healthcare & Life Sciences N | |||
FGSIX | 66.41 | 0.13 | +0.20% |
Federated Hermes MDT Mid Cap Growth IS | |||
LICOX | 17.19 | 0.02 | +0.12% |
Lord Abbett International Equity F3 | |||
AICFX | 60.23 | N/A | N/A |
American Funds Invmt Co of Amer F1 | |||
RYPMX | 169.86 | -1.21 | -0.71% |
Rydex Precious Metals Inv |